Stockhub

OBI Pharma, Inc.: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

23 September 2022

  • curprev 15:3115:31, 23 September 2022‎ Nick talk contribs‎ 852 bytes +852‎ Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == OBI Pharma, Inc., a biopharma company, develops and licenses novel therapeutic agents for unmet medical needs against cancer in Taiwan and internationally. It offers Adagloxad Simolenin (OBI-822), a breast cancer active immunity anti-cancer drug for generating antibody against tumor carbohydrate antigen Globo H; OBI-833, an immunity anti-cancer drug for the treatment of lung cancer; OBI-866 SSEA-4, an active immune-oncology..." Tag: Visual edit: Switched
Retrieved from ‘https://stockhub.co/research/OBI_Pharma,_Inc.’